COLLABORATIVE CLINICAL RESEARCH, INC. – Trademark Portfolio
Entity Type: 03
COLLABORATIVE CLINICAL RESEARCH, INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DATATRAK. The owner is based in Cleveland, OH.
20600 Chagrin Boulevard
Cleveland, OH 44122
Showing of trademarks Trademarks
Trademark Classifications
COLLABORATIVE CLINICAL RESEARCH, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does COLLABORATIVE CLINICAL RESEARCH, INC. have?
COLLABORATIVE CLINICAL RESEARCH, INC. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does COLLABORATIVE CLINICAL RESEARCH, INC. file in?
COLLABORATIVE CLINICAL RESEARCH, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are COLLABORATIVE CLINICAL RESEARCH, INC.'s most well-known trademarks?
COLLABORATIVE CLINICAL RESEARCH, INC.'s registered trademark portfolio includes well-known marks such as DATATRAK. These are among 1 currently registered trademark in the portfolio.
What is COLLABORATIVE CLINICAL RESEARCH, INC.'s trademark registration success rate?
COLLABORATIVE CLINICAL RESEARCH, INC. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.